Address And Details

100 Vanguard Blvd. , Malvern, PA 19355
Fund Manager Justin Schwartz
Manager Tenure 5 Years 8 Months

Strategy And Objective

The Fund seeks to provide current income that is exempt from federal personal income taxes, with limited price volatility. The Fund has no limitations on the maturity of individual securities but is expected to maintain a dollar-weighted average maturity of 1 to 2 years. At least 75% of the securities held by the Fund are municipal bonds in the top three credit-rating categories as determined by a nationally recognized statistical rating organization (NRSRO) (e.g., Aaa, Aa, and A by Moody's Investors Service, Inc. (Moody's)) or, if unrated, determined to be of comparable quality by the advisor. The Fund may invest up to 20% of its assets in medium-grade quality bonds, as determined by an NRSRO (e.g., Baa by Moody's) or by the advisor. The remaining 5% may be invested in securities with lower credit ratings or, if unrated, determined to be of comparable quality by the advisor.

Net Asset Value

as of 5:36 PM ET 09/28/2021

Performance

  • 1 Week
  • n/a
  • 1 Month
  • -0.19%
  • 3 Months
  • -0.19%
  • 1 Yr Return
  • -0.31%
  • 5 Yr Return
  • +0.57%

Equity Sector Breakdown

ConsumerDurables n/a
Energy n/a
Finance n/a
Health n/a
IndustrialCyclical n/a
NonDurables n/a
RetailTrade n/a
Services n/a
Technology n/a
Utilities n/a

Asset Allocation

Asset Type % Of Allocation
Bonds 96.88%
Cash 3.92%
Stocks 0.00%
Preferred 0.00%
Convertible 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Other -0.80%
Total Net Assets 972.26 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -0.01 -0.11 -0.02
Beta 0.17 0.16 0.13
R Squared 0.72 0.66 0.60
Std Deviation 0.79 0.77 0.62
Sharpe Ratio 0.85 0.31 n/a

Purchase Information

as of 5:40 PM ET 09/24/2021
Minimum Initial $3000
Minimum Additional $1
Minimum Initial IRA $0

Performance

Timeframe Average Annual Current Performance Monthly As Of 09/30/2021 Average Annual Current Performance Quarterly As Of 09/30/2021 Avg Annual Current Performance Monthly As Of 09/30/2021 Avg Annual Current Performance Quarterly As Of 09/30/2021
1 Year
  • +0.44%
  • +0.44%
+0.44% +0.44%
3 Year
  • +1.68%
  • +1.68%
+1.68% +1.68%
10 Year
  • +1.01%
  • +1.01%
+1.01% +1.01%
Life Of Fund
  • +3.67%
  • +3.67%
+3.67% +3.67%

Top 10 Holdings

Symbol Company Name % Of Assets
n/a

LATEST NEWS

Recent Articles from TheStreet

Nucor Lead

Cramer: Now Is Not the Time to Sell Nucor Steel Stock

Upside remains for steelmaker even after key downgrade, as infrastructure spending is still in play in Washington.

Levi Strauss Lead

Levi Strauss Bullish on Next-Gen Retail

The direct-to-consumer stores focus on local personalization, customization and digitalization.

Wall Street Lead

Cramer's Mad Money Recap: J&J, Netflix, Nvidia, Tesla

Cramer says the clouds over Wall Street may have broken. Get ready for next week's earnings parade.

Here Is What Jim Cramer Expects From Schlumberger's Earnings

Energy Stocks Emerge as Leaders: Curran

Years of underperformance appear over for hard-hit oil and gas stocks.

Dave Chappelle Netflix Lead

Netflix Employee Reportedly Laid Off Over Chappelle Show Leak

Internal unrest over content of comedian's latest program continues at streaming giant.

crypto copy

Stablecoin Issuer Tether Agrees to $41 Million Settlement with CTFC

Tether made 'untrue or misleading statements and omissions in connection with the U.S. dollar tether token stablecoin,' the CFTC said.

Boeing Invests $20 Million in Human Spaceflight Company Virgin Galactic

Virgin Galactic Could Fall Another 15%. Chart Shows Where to Buy Dip.

Virgin Galactic stock had verged on a breakout. Now it's dropping. Here's where we're looking to buy the dip.

The logo of Taiwan Semiconductor Manufacturing Co (TSMC) is pictured at its headquarters, in Hsinchu, Taiwan, Jan. 19, 2021. Photo: Reuters

Guilfoyle on the Biggest Threat to Taiwan Semiconductor

Chip foundry makes Taiwan an even bigger target for Beijing's aggressive moves.

Johnson & Johnson's vaccine Lead

Johnson & Johnson Covid Booster Backed by FDA Panel

Johnson & Johnson shares rose after an FDA advisory panel backed the authorization of boosters for the company's single-shot Covid-19 vaccine.

Moderna

Moderna Stock Slips as FDA Reportedly Delays Vaccine for Adolescents

Moderna shares slip on a report the FDA is delaying a decision to approve the company's COVID-19 vaccine for adolescents.